Hotline:
+ 49 (0) 2204 2918806

Market studies for category Pharmaceuticals

Items 1 to 10 of 3027 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 303
  1. Net price*
    Year
  2. $300.00
    2015
    Für diese Studie liegt keine Bewertung vor.

    CellSeed Inc. (7776) - Financial and Strategic SWOT Analysis Review

    GlobalData
    25 Pages
    CellSeed Inc. (CellSeed) is a biotechnology company. The company develops and provides innovative solutions for tissue-engineering through novel cell harvest methods. Its products include regenerative living cornea cells, living cardiac patch, and regenerative living cornea for pets which uses its proprietary UpCell technology. CellSeed o
    Englisch | Zukunftsanalyse | SKU: 145119
  3. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    NABsys, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    17 pages
    NABsys, Inc. (NABsys) is a life sciences company. The company designs and develops solid-state DNA sequencing platform. Its platform detects the positions of hybridized DNA probes and develops algorithms to reconstruct the DNA sequence. NABsys’s technology has applications in clinical diagnostics, drug development, and basic research. T
    Englisch | Zukunftsanalyse | SKU: 331536
  4. $300.00
    2015
    Für diese Studie liegt keine Bewertung vor.

    FDC Limited (FDC) - Financial and Strategic SWOT Analysis Review

    GlobalData
    25 Pages
    This comprehensive SWOT profile of FDC Limited provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps yo
    Englisch | Zukunftsanalyse | SKU: 85185
  5. $2,500.00
    2015
    Für diese Studie liegt keine Bewertung vor.

    Premature Ovarian Failure Global Clinical Trials Review, H2, 2015

    GlobalData
    45 pages
    GlobalData's clinical trial report, “Premature Ovarian Failure Global Clinical Trials Review, H2, 2015" provides an overview of Premature Ovarian Failure clinical trials scenario. This report provides top line data relating to the clinical trials on Premature Ovarian Failure. Report includes an overview of trial numbers and their averag
    Englisch | Marktstudie | SKU: 987689559
  6. $3,495.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Remicade (Crohn’s Disease) - Forecast and Market Analysis to 2022

    GlobalData
    48 pages
    The Crohn’s disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon. These compounds will challenge the current biologics in an attempt to dislodge the stronghold of the TNF inhibitors, as they aim to tap into the lucrative portion of the CD therapeutics market. If their promising safety and efficacy
    Englisch | Zukunftsanalyse | SKU: 402136
  7. $3,495.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    BAX-855 (Hemophilia A and B) - Forecast and Market Analysis to 2022

    GlobalData
    59 pages
    The competitive landscape of hemophilia A and B recombinant therapy in the US and 5EU is dominated by the use of recombinant FVIII and FIX replacement factors, and patients with severe forms of the disease receive frequent prophylactic infusions beginning from the first one or two years of life and often continuing through adulthood. Howe
    Englisch | Zukunftsanalyse | SKU: 387164
  8. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Clinuvel Pharmaceuticals Limited (CUV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    68 pages
    Clinuvel Pharmaceuticals Limited (Clinuvel Pharmaceuticals), formerly EpiTan Limited, is a biopharmaceutical company. The company carries out the development of photoprotective drug called Scenesse (afamelanotide) as a preventive treatment for a range of ultra violet (UV) and light related skin disorders. Scenesse provides skin protection
    Englisch | Zukunftsanalyse | SKU: 270852
  9. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    PharmAbcine, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    19 pages
    PharmAbcine, Inc. (PharmAbcine) is a biotechnology company. The company discovers and develops human therapeutic monoclonal antibody. Its products under clinical development include lead MAB and bi-specific MAB. PharmAbcine services offered by PharmAbcine are initial consultation, biopanning, screening by ELISA, mono-phage Ab sequence ana
    Englisch | Zukunftsanalyse | SKU: 387874
  10. $2,500.00
    2015
    Für diese Studie liegt keine Bewertung vor.

    Dystonia Global Clinical Trials Review, H1, 2015

    GlobalData
    90 pages
    GlobalData's clinical trial report, “Dystonia Global Clinical Trials Review, H1, 2015" provides data on the Dystonia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Dystonia. It includes an overview of the trial numbers and their recruitment status as per the site of trial
    Englisch | Zukunftsanalyse | SKU: 987680107
  11. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Alembic Pharmaceuticals Limited (APLLTD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    23 Pages
    Alembic Pharmaceuticals Limited (Alembic Pharma) is an integrated pharmaceutical company. It undertakes the development, manufacturing and marketing of pharmaceutical products, active pharmaceutical ingredients and intermediates. The company offers products and services in five divisions, namely, active pharmaceutical ingredients, bulk ph
    Englisch | Zukunftsanalyse | SKU: 159715

Items 1 to 10 of 3027 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 303